Transforming growth factor-β1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 283, Issue 4 46-4, 2002, Pages

  Chen, Anping ^a   Davis, Bernard H ^a   Sitrin, Michael D ^a   Brasitus, Thomas A ^a   Bissonnette, Marc ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

1,25 dihydroxyvitamin D3; Antiproliferative; Calcitriol; Colon cancer chemoprevention; Insulin like growth factor II receptor

Indexed keywords

CALCITRIOL; MESSENGER RNA; NEUTRALIZING ANTIBODY; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN CACO 2; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION;

EID: 0036783528     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00524.2001     Document Type: Article

References (53)

1. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors
2. Role of insulin-like growth factors in embryonic and postnatal growth
3. 3 and its metabolites/analogs
4. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex
5. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines
6. Rapid flux in transforming growth factor-beta receptors on bone cells
7. Transforming growth factor-beta protection of cancer cells against tumor necrosis factor cytotoxicity is counteracted by hyaluronidase
8. 3-induced inhibition of cell growth and stimulation of apoptosis in Caco-2 cells
9. UV irradiation activates JNK and increases alphaI(I) collagen gene expression in rat hepatic stellate cells
10. 1,25-Dihydroxyvitamin D(3) stimulates activator protein-1-dependent caco-2 cell differentiation
11. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor
12. Regulated expression of the integrin alpha9beta1 in the epithelium of the developing human gut and in intestinal cell lines: Relation with cell proliferation
13. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
14. Insulin-like growth factor II: Complexity of biosynthesis and receptor binding
15. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells
16. 1 Alpha,25-dihydroxyvitamin D3 inhibits normal human keratinocyte growth by increasing transforming growth factor beta 2 release
17. Human colon carcinoma cells (CaCo-2) synthesize IGF-II and express IGF-I receptors and IGF-II/M 6P receptors
18. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1
19. Cloning, characterization, and expression of the transforming growth factor-beta type I receptor promoter in fetal rat bone cells
20. Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor
21. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells
22. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells
23. Sodium butyrate alters the response of a human colon carcinoma cell line to transforming growth factor-beta 1
24. Smads bind directly to the Jun family of AP-1 transcription factors
25. Control of insulin-like growth factor-II/mannose 6-phosphate receptor gene transcription by proximal promoter elements
26. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene
27. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate
28. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain
29. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): Conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta
30. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
31. Calcium, vitamin D, and colorectal cancer: A review of the epidemiologic evidence
32. TGFbeta signaling: Receptors, transducers, and Mad proteins
33. Insulin-like growth factor II receptor as a multifunctional binding protein
34. Transforming growth factor-beta 1 modulates the effect of 1 alpha, 25-dihydroxyvitamin D3 on leukemic cells
35. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis
36. The human cation-independent mannose 6-phosphate receptor. Cloning and sequence of the full-length cDNA and expression of functional receptor in COS cells
37. Specificity, diversity, and regulation in TGF-beta superfamily signaling
38. Transforming growth factor beta
39. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta
40. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: Roles of cyclin E, p21Waf1, and p27Kip1
41. Mediation of differentiating effects of butyrate on the intestinal cell line Caco-2 by transforming growth factor-beta 1
42. 3 stimulates apoptosis in Caco-2 cells
43. Different growth patterns of a cancer cell population as a function of its starting growth characteristics: Analysis by mathematical modelling
44. Failure of programmed cell death and differentiation as causes of tumors: Some simple mathematical models
45. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner
46. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells
47. Platelet-derived growth factor is a principal inductive factor modulating mannose 6-phosphate/insulin-like growth factor-II receptor gene expression via a distal E-box in activated hepatic stellate cells
48. Type II TGF-(beta) receptor expression in intestinal cell lines and in the intestinal tract
49. Regulation of transforming growth factor-beta type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues
50. 1 Alpha,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells
51. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins
52. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators